STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,098 | -66.3% | 7,893 | -9.0% | 0.02% | -65.5% |
| Q2 2023 | $92,247 | -8.3% | 8,678 | -28.2% | 0.06% | 0.0% |
| Q1 2023 | $100,610 | -34.8% | 12,078 | -27.7% | 0.06% | -32.1% |
| Q4 2022 | $154,279 | +20.5% | 16,715 | +67.7% | 0.08% | +58.8% |
| Q3 2022 | $128,000 | -2.3% | 9,970 | +0.8% | 0.05% | +4.1% |
| Q2 2022 | $131,000 | -27.2% | 9,895 | +15.6% | 0.05% | -39.5% |
| Q1 2022 | $180,000 | -17.4% | 8,559 | -5.6% | 0.08% | -1.2% |
| Q4 2021 | $218,000 | +55.7% | 9,070 | +64.8% | 0.08% | +32.3% |
| Q3 2021 | $140,000 | -28.2% | 5,502 | -4.9% | 0.06% | -22.5% |
| Q2 2021 | $195,000 | -6.2% | 5,786 | +7.9% | 0.08% | -9.1% |
| Q1 2021 | $208,000 | -36.2% | 5,361 | +1.8% | 0.09% | -34.8% |
| Q4 2020 | $326,000 | – | 5,264 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |